Maximizing Treatment Outcome in OCD.

Trial Profile

Maximizing Treatment Outcome in OCD.

Completed
Phase of Trial: Phase III

Latest Information Update: 09 Dec 2015

At a glance

  • Drugs Risperidone (Primary)
  • Indications Obsessive-compulsive disorders
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 Nov 2015 Results assessing exposure and response prevention published in the Journal of Clinical Psychiatry (n = 32).
    • 11 Sep 2013 Primary endpoint 'Yale-Brown-Obsessive-Compulsive-Scale' has been met for cognitive behavioural therapy but not for risperidone according to results published in JAMA Psychiatry.
    • 11 Sep 2013 Results published in JAMA Psychiatry.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top